OT
Ovid Therapeutics Inc
🇺🇸XNAS.OVIDUnited StatesHealthcare
$2.69USDdown -0.05 (-1.82%)OpenEnd of day3:29 PM
Price$2.69-0.05 (-1.82%)
Profile
- Healthcare
- Biotechnology
- United States
Identity
- Exchange
- Nasdaq . XNAS
- Type
- Stock
- ISIN
- US6904691010
- CUSIP
- 690469101
Company
- Employees
- 23
- Headquarters
- New York, United States
- Website
- https://www.ovidrx.com
- CEO
- Ms. Margaret Alexander
Market
- Shares outstanding
- 195.3M
- Market cap
- $525.35M
Highlights
- Market cap
- $525.35M
- EPS LTM
- -$0.18calculatedCalculated by Finzer, not reported by the data provider.
- P/E LTM
- -15.23calculatedCalculated by Finzer, not reported by the data provider.
- Div yield
- Not reported
Fundamentals (LTM)
- Revenue
- $1.58M-76.2%down year on year
- Net income
- -$34.49M+9.65%up year on year
- Gross margin
- 92.92%+1.34%up year on year
- Free cash flow
- -$54.77M-36.64%down year on year
Other listings
These are the venues Finzer covers, not every venue that exists.
Business summary
No company summary reported yet.